GeoVax raises ~$3.2M in public offering of 13.2M units at $0.245/unit

GeoVax Labs, Inc.

Offering of 13,244,896 common units at $0.245/unit, each consisting of one share plus warrants for two shares.
Gross proceeds ~$3.2M; net proceeds ~$2.9M after placement agent fees and offering expenses.
Warrants exercisable immediately at $0.245/share, expire 5 years from issuance.
Roth Capital Partners acted as exclusive placement agent; closing on December 22, 2025.
Proceeds to be used for working capital and general corporate purposes.

item 1.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GeoVax Labs, Inc. entered into Placement Agency Agreement with Roth Capital Partners, LLC (effective 2025-12-19).

Action: entry
Agreement: underwriting
Counterparty: Roth Capital Partners, LLC
Effective: 2025-12-19

Exact text from the filing

On December 19, 2025, GeoVax Labs, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”)

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GeoVax Labs, Inc. entered into Purchase Agreement with the purchasers party thereto valued at aggregate of 13,244,896 common units (effective 2025-12-19).

Action: entry
Agreement: equity purchase
Counterparty: the purchasers party thereto
Value: aggregate of 13,244,896 common units
Effective: 2025-12-19

Exact text from the filing

On December 19, 2025, GeoVax Labs, Inc. (the “Company”) entered into a placement agency agreement (the “Placement Agency Agreement”) with Roth Capital Partners, LLC (the “Placement Agent”) and a securities purchase agreement (the “Purchase Agreement”) with the purchasers party thereto, pursuant to which the Company agreed to issue and sell, in a public offering (the “Offering”), an aggregate of 13,244,896 common units

View on SEC.gov

25 material agreements filed in the last 30 days. Browse all material agreements →

GeoVax Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-038547

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.